Wales international Brooks was diagnosed with stage two Hodgkin lymphoma in October but has completed his treatment and received the all clear at the end of last season.
The 25-year-old has been working to a modified fitness programme as he builds towards an imminent return to full training, having recovered from Hodgkin,Brook will remain at Vitality stadium for another two years. Its done deal for the player.
Alongside Christian Pulisic and Callum Hudson-Odoi, Hakim Ziyech is another Chelsea attacker who has been left on the fringes in terms of minutes on the pitch. Unsurprisingly, he’s also looking for a way out. Ajax director is in direct discussion with Hakim but he is waiting to clarify on Antony's future.
Watford and Aston Villa has reached to a full agreement on Ismaila Sarr deal to join Villa at a fee worthy €25m plus add ons.
Content created and supplied by: Hellen-Sports (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More